All News
Filter News
Found 14,873 articles
-
University of Michigan Health System Release: Second U-M Stem Cell Line Now Publicly Available to Help Researchers Find Treatments for Nerve Condition
4/26/2012
-
Verastem, Inc. to Present at the Deutsche Bank 37th Annual Health Care Conference
4/26/2012
-
Novelos Therapeutics, Inc. Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
4/24/2012
-
Protein Prevents DNA Damage in the Developing Brain and Might Serve as a Tumor Suppressor, St. Jude Children's Research Hospital Study
4/23/2012
-
Regulus Therapeutics, Inc. Receives Allowance from Japan and U.S. Patent Offices for HCV Intellectual Property, Expanding Leading Worldwide Patent Estate
4/23/2012
-
Nuvilex Release: April 2012 KonLin Letter Cites Cutting-Edge Technology for Stem Cells and Treatments for Cancer and Diabetes, and Reaffirms Buy Recommendation
4/20/2012
-
Cell Therapeutics, Inc. Pays $30 Million in Cash and Stock for S*Bio’s Selective JAK2 Inhibitor
4/19/2012
-
Stemline Therapeutics, Inc. Announces Two Presentations of Direct Injection Synthetic Peptide Vaccine for Brain Cancer, Now Being Developed as SL-701, at the Annual Meeting of the American Association for Cancer Research (AACR)
4/18/2012
-
Inform Genomics Announces Results of Study Predicting Risk of Oral Mucositis in Patients Undergoing High Dose Chemotherapy
4/18/2012
-
Two Repressor Genes Identified as Essential for Placental Development, Ohio State University Study
4/17/2012
-
Access Pharmaceuticals Announces Interim Data From MuGard Phase 4 Clinical Trial in Oral Mucositis
4/17/2012
-
Access Pharmaceuticals Announces Interim Data From MuGard Phase 4 Clinical Trial in Oral Mucositis
4/17/2012
-
MediStem, Inc. (Formerly known as Medistem Laboratories, Inc.) Industry/Academia Collaboration Leads to Nanotechnology Based
4/17/2012
-
VistaGen Therapeutics, Inc. Licenses Breakthrough Stem Cell Culture Technology to Speed Development of Drug Screening and Cell Therapy for Immune System Disorders
4/16/2012
-
New Fat Graft Procedure Promises Long-Term Results in Breast Reconstruction, University of Tor Vergata Study
4/13/2012
-
Verastem, Inc. to Present at the BioCentury Future Leaders in the Biotech Industry Conference
4/13/2012
-
St. Jude Children's Research Hospital Release: Chemotherapy Proves Life-Saving for Some Leukemia Patients Who Fail Induction Therapy
4/12/2012
-
BioMarCare Technologies Ltd. and Ariadne Inc. Receive $900,000 Grant from the BIRD Foundation to Support Joint Collaboration
4/12/2012
-
Bellicum Pharmaceuticals, Inc. Appoints Baylor College of Medicine's David M. Spencer as Chief Scientific Officer
4/12/2012
-
Marshall Edwards, Inc. Receives FDA Approval of Investigational New Drug Application for Clinical Testing of Oncology Drug Candidate ME-344
4/10/2012